Five genes associated with the prognosis of glioma (ECI2, MCCC2, OXCT1, SUCLG2, and CPT2) were revealed and then, validated using glioma tissues, providing novel insights into individualized treatment and prognosis. This evidence concerns the gene MCCC2 and central nervous system cancer.